Singapore markets closed

Nuvation Bio Inc. (NUVB)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
3.6400-0.3300 (-8.31%)
At close: 04:00PM EDT
3.6900 +0.05 (+1.37%)
After hours: 07:59PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 797.33M
Enterprise value 190.12M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)1.32
Enterprise value/revenue N/A
Enterprise value/EBITDA -1.91

Trading information

Stock price history

Beta (5Y monthly) 1.19
52-week change 3119.28%
S&P500 52-week change 327.86%
52-week high 34.1600
52-week low 30.9500
50-day moving average 32.0034
200-day moving average 31.6303

Share statistics

Avg vol (3-month) 31.15M
Avg vol (10-day) 33.52M
Shares outstanding 5218.05M
Implied shares outstanding 6219.05M
Float 8122.88M
% held by insiders 127.00%
% held by institutions 162.01%
Shares short (15 Mar 2024) 42.82M
Short ratio (15 Mar 2024) 43.45
Short % of float (15 Mar 2024) 42.38%
Short % of shares outstanding (15 Mar 2024) 41.29%
Shares short (prior month 15 Feb 2024) 42.6M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-9.65%
Return on equity (ttm)-12.03%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -99.6M
Net income avi to common (ttm)-75.8M
Diluted EPS (ttm)-0.3500
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)611.21M
Total cash per share (mrq)2.79
Total debt (mrq)4.01M
Total debt/equity (mrq)0.66%
Current ratio (mrq)44.11
Book value per share (mrq)2.76

Cash flow statement

Operating cash flow (ttm)-68M
Levered free cash flow (ttm)-41.59M